Siemens Healthineers gains FDA clearance for Biograph Vision PET/CT system

Siemens Healthineers announced this week that its Biograph Vision PET/CT imaging system has gained FDA clearance.

Biograph Vision includes new technology that allowed the company to reduce the detector’s lutetium oxyorthosilicate crystal elements from 4-by-4 mm to 3.2-by-3.2 mm, improving its spatial resolution. This helped the system reduce scan time significantly.

Biograph Vision also has a 78-cm bore that can be placed in any location that had previously housed a Biograph PET/CT scanner without making major changes.

“The Biograph Vision represents a major leap in performance beyond any PET/CT system previously manufactured,” Jim Williams, PhD, head of Siemens Healthineers Molecular Imaging, said in a prepared statement. “With this system, we extend the boundaries of PET imaging and help our customers explore a new frontier in precision medicine.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.